Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Aventis Pharma is shopping for an agency to handle its Nasacort nasal spray for allergies, the company confirmed.
A representative for the Bridgewater, N.J., pharmaceuticals marketer, while confirming that the firm is looking for an agency for Nasacort, declined to give details on the review or say who has handled the brand so far.
Sources said the competition could be close to completion.
Aventis spent $8 million on Nasacort from March, when the first spending was recorded, through May, according to CMR, projecting to an estimated $30 million annual outlay.
The company’s other major allergy medication, Allegra, is now handled by McCann-Erickson in New York.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in